Chartwell Investment Partners, LLC Neurocrine Biosciences Inc Transaction History

Chartwell Investment Partners, LLC

$2.91 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$75.79 - $100.07 $8,033 - $10,607	106 Added 1.52%	7,086 $691,000
Q1 2022 Apr 26, 2022	BUY	$72.45 - $94.81 $29,559 - $38,682	408 Added 6.21%	6,980 $654,000
Q3 2021 Nov 16, 2021	SELL	$86.18 - $99.03 $1.32 Million - $1.51 Million	-15,271 Reduced 69.91%	6,572 $630,000
Q2 2021 Jul 19, 2021	SELL	$89.43 - $102.27 $1,252 - $1,431	-14 Reduced 0.06%	21,843 $2.13 Million
Q1 2021 May 03, 2021	SELL	$87.57 - $119.4 $190,464 - $259,695	-2,175 Reduced 9.05%	21,857 $2.13 Million
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $18,598 - $23,182	214 Added 0.9%	24,032 $2.3 Million
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $472,914 - $664,667	4,918 Added 26.02%	23,818 $2.29 Million
Q2 2020 Jul 29, 2020	BUY	$85.09 - $130.36 $1.09 Million - $1.67 Million	12,782 Added 208.92%	18,900 $2.31 Million
Q1 2020 Apr 30, 2020	SELL	$75.11 - $113.76 $22,533 - $34,128	-300 Reduced 4.67%	6,118 $530,000
Q3 2019 Oct 29, 2019	SELL	$83.82 - $101.5 $15,255 - $18,473	-182 Reduced 2.76%	6,418 $578,000
Q2 2019 Aug 19, 2019	SELL	$72.24 - $91.27 $108,865 - $137,543	-1,507 Reduced 18.59%	6,600 $557,000
Q1 2019 Apr 11, 2019	BUY	$69.31 - $91.53 $28,625 - $37,801	413 Added 5.37%	8,107 $714,000
Q4 2018 Feb 01, 2019	SELL	$68.32 - $124.36 $24,731 - $45,018	-362 Reduced 4.49%	7,694 $549,000
Q3 2018 Nov 08, 2018	SELL	$98.88 - $125.85 $3.28 Million - $4.17 Million	-33,122 Reduced 80.44%	8,056 $990,000
Q2 2018 Aug 09, 2018	SELL	$75.3 - $105.99 $1.59 Million - $2.24 Million	-21,104 Reduced 33.88%	41,178 $4.05 Million
Q1 2018 May 08, 2018	BUY	$75.88 - $92.43 $77,625 - $94,555	1,023 Added 1.67%	62,282 $4.83 Million
Q1 2018 May 08, 2018	SELL	$75.88 - $92.43 $77,625 - $94,555	-1,023 Reduced 1.64%	61,259 $5.08 Million
Q4 2017 Feb 08, 2018	SELL	$58.53 - $77.59 $652,375 - $864,818	-11,146 Reduced 15.18%	62,282 $4.83 Million
Q3 2017 Nov 08, 2017	BUY	$47.97 - $61.28 $3.52 Million - $4.5 Million	73,428	73,428 $4.5 Million

Others Institutions Holding NBIX

# of Institutions

638

Shares Held

93.8M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.15 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.52 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$782 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$391 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$283 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Account